These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 22612609
1. Estrogen and progestogen effect on venous thromboembolism in menopausal women. Archer DF, Oger E. Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609 [Abstract] [Full Text] [Related]
2. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K, Oger E. Rev Prat; 2005 Feb 28; 55(4):389-92. PubMed ID: 15828617 [Abstract] [Full Text] [Related]
3. Estrogen plus progestin and risk of venous thrombosis. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR, Women's Health Initiative Investigators. JAMA; 2004 Oct 06; 292(13):1573-80. PubMed ID: 15467059 [Abstract] [Full Text] [Related]
4. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators. J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858 [Abstract] [Full Text] [Related]
5. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Kuhl H, Stevenson J. Gynecol Endocrinol; 2006 Jun 21; 22(6):303-17. PubMed ID: 16785155 [Abstract] [Full Text] [Related]
6. Menopause and stroke and the effects of hormonal therapy. Lobo RA. Climacteric; 2007 Oct 21; 10 Suppl 2():27-31. PubMed ID: 17882669 [Abstract] [Full Text] [Related]
7. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Circulation; 2007 Feb 20; 115(7):840-5. PubMed ID: 17309934 [Abstract] [Full Text] [Related]
8. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L. Climacteric; 2010 Oct 20; 13(5):429-32. PubMed ID: 20670199 [Abstract] [Full Text] [Related]
9. Venous thrombosis and conjugated equine estrogen in women without a uterus. Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR. Arch Intern Med; 2006 Apr 10; 166(7):772-80. PubMed ID: 16606815 [Abstract] [Full Text] [Related]
10. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. Roach RE, Lijfering WM, Helmerhorst FM, Cannegieter SC, Rosendaal FR, van Hylckama Vlieg A. J Thromb Haemost; 2013 Jan 10; 11(1):124-31. PubMed ID: 23136837 [Abstract] [Full Text] [Related]
11. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators. Am J Epidemiol; 2006 Apr 01; 163(7):589-99. PubMed ID: 16484450 [Abstract] [Full Text] [Related]
12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens. Scarabin PY, Hemker HC, Clément C, Soisson V, Alhenc-Gelas M. Menopause; 2011 Aug 01; 18(8):873-9. PubMed ID: 21487317 [Abstract] [Full Text] [Related]
13. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial. Cravioto MD, Durand-Carbajal M, Jiménez-Santana L, Lara-Reyes P, Seuc AH, Sánchez-Guerrero J. Arthritis Care Res (Hoboken); 2011 Dec 01; 63(12):1654-63. PubMed ID: 22127965 [Abstract] [Full Text] [Related]
14. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT. Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666 [Abstract] [Full Text] [Related]
15. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view. Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. J Steroid Biochem Mol Biol; 2014 Jul 16; 142():4-11. PubMed ID: 24172877 [Abstract] [Full Text] [Related]
16. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire Int; 2004 Jun 16; 13(71):106-9. PubMed ID: 15233153 [Abstract] [Full Text] [Related]
17. Hormone therapy and venous thromboembolism among postmenopausal women. Scarabin PY. Front Horm Res; 2014 Jun 16; 43():21-32. PubMed ID: 24943295 [Abstract] [Full Text] [Related]
18. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Weiss NS, Larson EB, Rosendaal FR, Psaty BM. JAMA; 2004 Oct 06; 292(13):1581-7. PubMed ID: 15467060 [Abstract] [Full Text] [Related]
19. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT. Brown S. Menopause Int; 2013 Dec 06; 19(4):145. PubMed ID: 24479171 [No Abstract] [Full Text] [Related]
20. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Scarabin PY. Arterioscler Thromb Vasc Biol; 2010 Feb 06; 30(2):340-5. PubMed ID: 19834106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]